Business & Economy · 27 views
Biogen Hits 52 - Week High , Alzheimer Drug Sales Jump
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59. The Alzheimer
Business & Economy 
Story intelligence
Coverage Single outlet Single-outlet story
Views 27 Community interest
Brief read Under 1 min brief 19 words
Summary
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- The traditional paths to building wealth are becoming less accessible for young AmericansContinue reading
- Dow drops 500 points to start shortened week as oil prices climb: Live updatesContinue reading
- ‘Poverty doesn’t have to be my reality’: I thought I’d have to rely on Social Security. Then I taught myself how to invest.Continue reading
- The Economic Fallout From a Potential Return to $100 OilContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow